115 related articles for article (PubMed ID: 37923009)
1. Niosomes based formulation containing tenoxicam: A newer solution for the rheumatic diseases.
Maheshwari R; Sharma M; Chidrawar VR
Ann Pharm Fr; 2024 May; 82(3):473-482. PubMed ID: 37923009
[TBL] [Abstract][Full Text] [Related]
2. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
3. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
4. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
5. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
6. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
7. Formulation and pharmacodynamic evaluation of glibenclamide incorporated niosomal gel.
Vadlamudi HC; Yalavarthi PR; Satyanarayana RP; Vandana K; Vulava J; Gutta TC
Curr Drug Discov Technol; 2014; 11(3):189-96. PubMed ID: 25176281
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426
[TBL] [Abstract][Full Text] [Related]
9. Enhanced nuclear translocation and activation of aryl hydrocarbon receptor (AhR) in THP-1 monocytic cell line by a novel niosomal formulation of indole-3-carbinol.
Abbaspour Sani N; Hasani M; Kianmehr A; Mohammadi S; Sheikh Arabi M; Yazdani Y
J Liposome Res; 2020 Jun; 30(2):117-125. PubMed ID: 30917715
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
12. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study.
Zaid Alkilani A; Hamed R; Abdo H; Swellmeen L; Basheer HA; Wahdan W; Abu Kwiak AD
ACS Omega; 2022 Nov; 7(44):39782-39793. PubMed ID: 36385887
[TBL] [Abstract][Full Text] [Related]
14. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
15. Etodolac Containing Topical Niosomal Gel: Formulation Development and Evaluation.
Shilakari Asthana G; Asthana A; Singh D; Sharma PK
J Drug Deliv; 2016; 2016():9324567. PubMed ID: 27478643
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
17. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
18. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
Kumbhar D; Wavikar P; Vavia P
AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
20. Quality-by-Design-Assisted Optimization of Carvacrol Oil-Loaded Niosomal Gel for Anti-Inflammatory Efficacy by Topical Route.
Ghazwani M; Hani U; Alam A; Alqarni MH
Gels; 2023 May; 9(5):. PubMed ID: 37232993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
